0001140361-17-018919.txt : 20170508
0001140361-17-018919.hdr.sgml : 20170508
20170508183024
ACCESSION NUMBER: 0001140361-17-018919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170505
FILED AS OF DATE: 20170508
DATE AS OF CHANGE: 20170508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AYERS JONATHAN W
CENTRAL INDEX KEY: 0001184149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 17823871
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
4
1
doc1.xml
FORM 4
X0306
4
2017-05-05
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001184149
AYERS JONATHAN W
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
1
0
0
Chairman, President & CEO
Common Stock
2017-05-05
4
M
0
30000
38.7950
A
1040994
D
Common Stock
2017-05-05
4
S
0
26000
160.6130
D
1014994
D
Common Stock
98000
I
by Ayers Family Trust
Non-Qualified Stock Option (right-to-buy)
38.7950
2017-05-05
4
M
0
30000
D
2018-02-13
Common Stock
30000
10000
D
Includes 47 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2017.
Represents the weighted average sales price of the shares sold ranging from a low of $160.40 to a high of $160.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Grant of option to buy 58,712 shares of IDEXX Laboratories, Inc. common stock that became exercisable in four annual installments of 12,000 shares each beginning on February 14, 2012 and as to the remaining 10,712 shares on February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers
2017-05-08